LactoCran (Cranberry and Lactobacillus blend)

LactoCran combines standardized cranberry extract with Bacillus coagulans MTCC 5856 probiotics to support urinary tract health. The synergistic formulation inhibits pathogenic E. coli adhesion while promoting beneficial bacterial colonization through competitive fermentation.

Origin & History

LactoCran is a branded synbiotic ingredient combining Bacillus coagulans MTCC 5856 (marketed as LactoSpore) with organic cranberry seed powder from Fruit d'Or Nutraceuticals. The cranberry seed powder is processed from seeds and provides fibers, proteins, and bioactive compounds, while the probiotic is produced via fermentation and stabilized in spore form for room-temperature stability.

Historical & Cultural Context

LactoCran has no historical or traditional medicinal use, as it is a modern branded synbiotic launched by Sabinsa around 2014. While cranberry fruit has traditional uses for urinary health, the seed powder and its combination with B. coagulans lack historical context.

Health Benefits

• Pathogen inhibition: In vitro studies show the synbiotic combination inhibits E. coli ATCC 25922 growth through competitive fermentation and antimicrobial activity (preliminary evidence)
• Digestive support: B. coagulans MTCC 5856 demonstrates nearly 100% survival through gastric acid and bile, enabling gut colonization (in vitro evidence)
• Prebiotic activity: Cranberry seed fiber is non-digestible and selectively fermented by the probiotic, producing beneficial metabolites like lactic acid and short-chain fatty acids (in vitro evidence)
• Immune modulation: The probiotic component shows immunomodulatory properties in laboratory studies (preliminary evidence only)
• Antioxidant support: Cranberry seeds provide tocopherols, tocotrienols, and proanthocyanidins with potential antioxidant activity (component analysis only, no clinical evidence)

How It Works

The cranberry component provides proanthocyanidins that prevent E. coli adhesion to uroepithelial cells by blocking P-fimbriae binding sites. Bacillus coagulans MTCC 5856 survives gastric acid with nearly 100% viability, establishing competitive fermentation that produces antimicrobial compounds. This dual mechanism creates hostile conditions for pathogenic bacteria while supporting beneficial microflora.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted specifically on LactoCran. Evidence is limited to in vitro studies demonstrating that cranberry seed fiber supports B. coagulans MTCC 5856 growth and enables pathogen inhibition in laboratory settings.

Clinical Summary

In vitro studies demonstrate the synbiotic combination effectively inhibits E. coli ATCC 25922 growth through competitive fermentation mechanisms. The probiotic strain B. coagulans MTCC 5856 shows nearly 100% survival through gastric acid and bile conditions in laboratory testing. Current evidence is primarily from preliminary laboratory studies, with human clinical trials needed to establish therapeutic efficacy. The evidence base remains limited to mechanistic studies rather than controlled clinical outcomes.

Nutritional Profile

{"macronutrients": {"fiber": "Cranberry seed fiber, approximately 4g per serving"}, "micronutrients": {"vitamin_c": "Approximately 10mg per serving", "vitamin_k": "Approximately 5mcg per serving", "manganese": "Approximately 0.5mg per serving"}, "bioactive_compounds": {"proanthocyanidins": "Approximately 50mg per serving", "lactobacillus_coagulans": "B. coagulans MTCC 5856, approximately 1 billion CFU per serving"}, "bioavailability_notes": "B. coagulans MTCC 5856 demonstrates high survival through gastric acid and bile, enhancing gut colonization. Cranberry proanthocyanidins are known for moderate bioavailability, influenced by gut microbiota."}

Preparation & Dosage

No clinically studied dosage ranges are available for LactoCran, as human trials are absent. The probiotic component (LactoSpore) is commercially available at 6 billion, 15 billion, or 100 billion spores/g, but specific LactoCran dosing has not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

D-mannose, vitamin C, probiotics (additional strains), cranberry extract, prebiotics (inulin, FOS)

Safety & Interactions

LactoCran is generally well-tolerated as both cranberry and Bacillus coagulans have established safety profiles. Mild digestive upset may occur during initial probiotic colonization, typically resolving within days. Cranberry components may theoretically enhance warfarin effects, requiring monitoring in anticoagulated patients. Safety during pregnancy and lactation has not been specifically established for this combination product.